Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
HIV Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
Anti-HIV Agents Medicine & Life Sciences
Drug Interactions Medicine & Life Sciences
efavirenz Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1976 2018

Long-acting formulations for the treatment of latent tuberculous infection: Opportunities and challenges

Swindells, S., Siccardi, M., Barrett, S. E., Olsen, D. B., Grobler, J. A., Podany, A. T., Nuermberger, E., Kim, P., Barry, C. E., Owen, A., Hazuda, D. & Flexner, C. Feb 1 2018 In : International Journal of Tuberculosis and Lung Disease. 22, 2, p. 125-132 8 p.

Research output: Contribution to journalReview article

Tuberculosis
Infection
HIV
Drug Compounding
Virus Diseases
efavirenz
Rifampin
Drug Interactions
Tenofovir
Therapeutics

In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents

Rajoli, R. K. R., Back, D. J., Rannard, S., Meyers, C. F., Flexner, C., Owen, A. & Siccardi, M. May 24 2017 (Accepted/In press) In : Clinical Pharmacokinetics. p. 1-12 12 p.

Research output: Contribution to journalArticle

Rilpivirine
Computer Simulation
Pharmacokinetics
Injections
Physiological Phenomena

The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development

Smith, J. M. & Flexner, C. Jun 1 2017 In : AIDS. 31, p. S173-S184

Research output: Contribution to journalArticle

Polypharmacy
HIV
Drug Interactions
Comorbidity
Population

Universal antiretroviral regimens: thinking beyond one-pill-once-a-day

Jacobson, J. M. & Flexner, C. Mar 31 2017 (Accepted/In press) In : Current Opinion in HIV and AIDS.

Research output: Contribution to journalArticle

Rilpivirine
Monoclonal Antibodies
HIV Infections
HIV-1
Clinical Trials